Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator - ScienceDirect
Profile of lumacaftor/ivacaftor combination: potential in the treatmen | ODRR
Frontiers | CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine | Pharmacology
Form S-1
New Research on the Importance of Cystic Fibrosis Transmembrane Conductance Regulator Function for Optimal Neutrophil Activity | IntechOpen
Ivacaftor for cystic fibrosis | The BMJ
The different classes of CFTR gene mutations and the mechanisms of... | Download Scientific Diagram
How It Works | TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor)
Elexacaftor–tezacaftor–ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation - ScienceDirect
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives - Document - Gale OneFile: Health and Medicine
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects | Semantic Scholar
Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation. - Abstract - Europe PMC
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial - The Lancet
CFTR: New insights into structure and function and implications for modulation by small molecules - Journal of Cystic Fibrosis
Cureus | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
Lumacaftor/ivacaftor - Wikipedia
Orkambi (lumacaftor/ivacaftor) for the Treatment of Cystic Fibrosis (CF) - Clinical Trials Arena
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease | European Respiratory Society
Combination therapy in Phe508del CFTR: how many will be enough?
Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/ Ivacaftor? - Schneider - 2017 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Cystic fibrosis: novel therapies, remaining challenges - Coulthard - 2018 - Journal of Pharmacy Practice and Research - Wiley Online Library
Lumacaftor | C24H18F2N2O5 - PubChem
